News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

New Financial Objectives for Vitrolife


10/1/2012 10:59:15 AM

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: After the adoption of a resolution to spin off Vitrolife’s (STO:VITR) transplantation business, Vitrolife’s Board has set new financial objectives for the company.

Vitrolife’s new financial objectives are as follows:

Vitrolife’s Board considers that Vitrolife should have a strong capital base in order to enable continued high growth, both organically and through acquisitions. The company’s net debt in relation to EBITDA should normally not exceed 3 times. Vitrolife’s Board targets a profitable growth. The objective for Vitrolife’s growth over a three year period is an increase in sales by an average of 20 percent per year, with an operating margin of 15 percent.


Read at BioSpace.com


comments powered by Disqus
Vitrolife
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES